Expression of Concern: antenatal steroids at 37 weeks, does it reduce neonatal respiratory morbidity? A randomized trial

This article refers to:

Antenatal steroids at 37 weeks, does it reduce neonatal respiratory morbidity? A randomized trial

We, the Editors and Publisher of The Journal of Maternal-Fetal and Neonatal Medicine are issuing an expression of concern for the following article:

Magdy Refaat Ahmed, Waleed Ali Sayed Ahmed & Tamer Yahya Mohammed (2015) Antenatal steroids at 37 weeks, does it reduce neonatal respiratory morbidity? A randomized trial, The Journal of Maternal-Fetal & Neonatal Medicine, 28:12, 1486-1490, DOI: 10.3109/14767058.2014.958461

After publication of this article, questions about the scientific integrity of the article were brought to the Publisher and Editors’ attention. We reached out to the authors to request their raw data, which they have kindly provided. As this investigation may take some time to resolve, we advise readers to interpret the information presented in the article with due caution.

The authors have been notified about this Expression of Concern.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.